This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB06973/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/drug/DB06973/identifier/pubchem-compound/
n11http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB06973/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB06973/identifier/drugbank/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/resource/drugbank/drug/DB06973/identifier/chemspider/
n14http://linked.opendata.cz/resource/drugbank/drug/DB06973/identifier/chebi/

Statements

Subject Item
n2:DB06973
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n10:DB06973 n11:DB06973
dcterms:title
4,4'-PROPANE-2,2-DIYLDIPHENOL
adms:identifier
n4:6623 n7:99443444 n12:DB06973 n13:2OH n14:33216 n15:6371
n5:IUPAC-Name
n6:271B642C-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B6432-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B6431-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B642E-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B642F-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B6430-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B642A-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B642B-363D-11E5-9242-09173F13E4C5 n6:271B6428-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B6429-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B6438-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B6439-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B6433-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B6434-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B6436-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B6435-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B6437-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B643E-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B6440-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B6441-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B643D-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B643C-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B643F-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B642D-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B643A-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B643B-363D-11E5-9242-09173F13E4C5